Nabriva Therapeutics Plc
NBRVF
Revenue
2.24M
▼-5.35M▼-70.45%
3 Months ChangeAssets
10.58M
▼-13.76M▼-56.54%
3 Months ChangeLiabilities
26.90M
▼-1.80M▼-6.26%
3 Months ChangeFree Cash Flow
-5.62M
▲10.28M▲64.66%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2023-10-19
Form 10-Q
ID: 0001558370-23-016524
2023-07-31
Form 8-K
ID: 0001104659-23-085605
2023-07-24
Form 8-K
ID: 0001104659-23-083250
2023-07-07
Form 8-K
ID: 0001104659-23-079156
2023-06-01
Form 8-K
ID: 0001104659-23-067071
2023-05-22
Form 10-Q
ID: 0001558370-23-010302
2023-02-06
Form 8-K
ID: 0001104659-23-010788
2023-01-20
Form 8-K
ID: 0001104659-23-005144
2023-01-09
Form 8-K
ID: 0001104659-23-002268
2022-11-28
Form 8-K
ID: 0001104659-22-122226